查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717101

体外二氧化碳去除装置市场（按产品类型、存取、操作模式、应用和最终用户）—2025-2030 年全球预测

Extracorporeal CO2 Removal Devices Market by Product Types, Access, Mode of Operation, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

体外二氧化碳去除装置市场预计在 2024 年达到 1.4755 亿美元，在 2025 年成长至 1.5968 亿美元，到 2030 年达到 2.4018 亿美元，复合年增长率为 8.45%。

主要市场统计数据
基准年2024年 1.4755亿美元
预计2025年 1.5968亿美元
预测年份 2030 2.4018亿美元
复合年增长率（%） 8.45%

体外二氧化碳去除装置已成为现代呼吸护理的重要解决方案，为患有严重肺部疾病的患者提供了策略选择。近年来，这项技术经历了重大创新和改进，改变了临床医生处理呼吸窘迫的方式。急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD) 等疾病的盛行率不断上升，以及对肺移植桥樑的需求不断增长，都促进了充满活力且竞争激烈的市场的扩张。

该领域的进步不仅限于单纯的技术进步，还包括整合复杂的设计功能和增强的安全通讯协定。在尖端研发的支持下，这些设备提高了气体交换过程的效率，同时最大限度地降低了体外治疗固有的风险。推动自动化和简化流程也减少了对人工干预的依赖，提高了可靠性和病人安全性。

此外，跨学科合作在该领域发挥着至关重要的作用。创新源于工程、临床专业知识和强大的数据分析的交叉。相关人员发现，这种有凝聚力的方法不仅加速了产品开发，而且还使技术性能与不断变化的临床需求保持一致。因此，这个市场不仅代表着成长的机会，也代表着重新定义患者照护标准的机会。该报告详细回顾了影响市场的新兴趋势、关键细分见解和变革性变化，最终成为行业领导者和决策者的重要指南。

体外二氧化碳去除装置格局的变革时期

该行业已经经历了几次变革，正在重塑外部二氧化碳去除技术的格局。材料科学和生物医学工程的进步使製造商能够优化设备性能，从而实现更有效的气体交换并降低併发症率。自动化一直是技术进步的主要驱动力，改进的电脑控制和即时监控系统使医疗保健专业人员能够更精确地执行复杂的流程。

经济变化也发挥了作用，成本效益的驱动迫使医疗保健提供者采用能够提供高性能和永续营运的创新。此外，对以患者为中心的护理的日益重视促进了设备的发展，这些设备不仅更高效，而且侵入性更小，从而显着改善了患者的治疗效果和长期治疗期间的舒适度。新兴技术、经济和患者照护优先事项的结合正在推动市场摆脱传统模式并采用下一代解决方案。

监管变化也是一个关键因素，因为更严格的安全性和有效性标准要求製造商不断改进其产品。产业相关人员、学术机构和临床专家之间加强合作有助于更丰富、更全面地了解患者需求和治疗反应。同时，新兴的数据分析和数位健康应用正在发挥支援作用，提供可行的见解，为设计改进和临床决策提供资讯。这种转变正在为性能和效率树立新的标桿，为持续创新和市场扩张铺平道路。

关键市场区隔洞察

体外二氧化碳去除的市场细分提供了对不同动态的细緻理解。基于产品类型的细分尤为明显，突出了设备从传统 ECCO2R 设备到先进的膜式氧合器和复杂的滚压泵系统的演变。同时，基于通路的分割区分两种主要方法：动脉和静脉。每种方法都代表了针对患者和血流动力学管理的截然不同的方法论。

当考虑操作模式时，自动系统和手动系统之间有明显的对比。这种差异凸显了人们对自动化日益增长的偏好，这有助于降低操作复杂性并提高整体效能。此外，将重点转移到应用上，市场具有不同的使用模式，例如管理急性呼吸窘迫症候群、肺移植桥接以及管理慢性阻塞性肺病。这些应用将进一步决定治疗策略并影响设备设计。

最后，按最终用户细分，凸显了不同医疗保健环境（从门诊手术中心和居家医疗机构到医院和专科诊所）的需求变化。每个部分都对区域差异、临床要求和潜在技术采用提供了独特的见解。这些细分参数的交集描绘出一幅全面的整体情况，将指南製造商和政策制定者制定策略以满足当前和未来的市场需求。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 急性呼吸衰竭、严重气喘及慢性阻塞性肺病盛行率上升
      • 医疗保健专业人士对非侵入式二氧化碳去除解决方案的认识日益提高
      • 扩大医疗基础设施并增加人均支出
    • 限制因素
      • 与 ECCO2R 系统运作相关的技术整合风险；
    • 机会
      • 增加体外二氧化碳去除装置技术进步的研究、开发与资金投入
      • 增加监管产品核可和设备临床试验
    • 任务
      • 管理供应链的复杂性并确保远距医疗站点的设备可用性
  • 市场区隔分析
    • 产品类型：增加使用 ECCO2R 设备进行体外二氧化碳移除以治疗严重肺部併发症
    • 应用：急性呼吸窘迫症候群装置在体外二氧化碳移除装置的扩展应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 外部二氧化碳去除装置市场（依产品类型）

  • ECCO2R机器
  • 膜式氧合器
  • 滚压泵

7. 外部二氧化碳去除设备市场进入）

  • 动脉和静脉
  • 静脉

8. 体外二氧化碳去除装置市场（依操作模式）

  • 自动化系统
  • 手动系统

第九章体外二氧化碳去除装置市场：依应用

  • 急性呼吸窘迫症候群
  • 肺移植的桥樑
  • 慢性阻塞性肺病

第 10 章。体外二氧化碳去除装置市场（依最终用户划分）

  • 门诊手术中心
  • 居家照护环境
  • 医院
  • 专科诊所

第 11 章美洲体外二氧化碳移除装置市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12.亚太地区体外二氧化碳去除装置市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲体外二氧化碳去除装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Aferetica Srl
  • ALung Technologies, Inc. by LivaNova PLC
  • Baxter International Inc.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Estor SpA
  • Fresenius Medical Care AG
  • Getinge AB
  • Inspira-Technologies OXY BHN LTD
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medica SpA
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • NovaLung GmbH
  • Terumo Corporation
  • X-COR Therapeutics
  • XENIOS AG by Fresenius Medical Care AG & Co. KGaA
Product Code: MRR-F927BA462E0F

The Extracorporeal CO2 Removal Devices Market was valued at USD 147.55 million in 2024 and is projected to grow to USD 159.68 million in 2025, with a CAGR of 8.45%, reaching USD 240.18 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 147.55 million
Estimated Year [2025] USD 159.68 million
Forecast Year [2030] USD 240.18 million
CAGR (%) 8.45%

Extracorporeal CO2 Removal Devices have emerged as a critical solution in modern respiratory care, offering a strategic alternative for patients suffering from severe pulmonary conditions. In recent years, this technology has experienced significant innovations and improvements, transforming the way clinicians manage respiratory distress. The increasing prevalence of conditions such as Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), and the rising demand to bridge to lung transplant have all contributed to an expanding market that is both dynamic and highly competitive.

The evolution in this space is not confined merely to technological advancements but extends to the integration of sophisticated design features and enhanced safety protocols. Underpinned by cutting-edge research and development, these devices have achieved improved efficiency in gas exchange processes while minimizing the inherent risks associated with extracorporeal therapies. The drive towards automation and streamlined processes has also reduced the dependency on manual intervention, thereby bolstering both reliability and patient safety.

Furthermore, the role of interdisciplinary collaboration in this sector has been pivotal. Innovations are emerging from an amalgamation of engineering, clinical expertise, and robust data analytics. Stakeholders are finding that this cohesive approach not only accelerates product development but also aligns the technical performance with the evolving clinical needs. As such, the market presents not just an opportunity for growth but also a chance to redefine patient care standards. This report provides an in-depth review of the rising trends, key segmentation insights, and the transformative shifts impacting the market, ultimately serving as an essential guide for industry leaders and decision-makers.

Transformative Shifts in the Landscape of Extracorporeal CO2 Removal Devices

The industry has witnessed several transformative shifts that are reshaping the landscape of extracorporeal CO2 removal technologies. Advances in material sciences and biomedical engineering have allowed manufacturers to optimize device performance, leading to more efficient gas exchange and reduced complication rates. The technological progression is largely driven by an increasing focus on automation, where enhanced computerized controls and real-time monitoring systems empower healthcare professionals to execute complex processes with improved precision.

Economic shifts have also played a role, as the drive for cost-effectiveness pressures providers to adopt innovations that deliver both high performance and sustainable operation. Moreover, the growing emphasis on patient-centered care has catalyzed the development of devices that are not only efficient but also minimally invasive, which significantly improves patient outcomes and comfort during extended therapies. This synthesis of advanced technology, economic prudence, and patient care priorities is driving the market to move away from traditional paradigms and embrace next-generation solutions.

Regulatory changes are another critical factor, with stringent safety and efficacy standards compelling manufacturers to continually refine their product offerings. Increased collaboration between industry players, academic institutions, and clinical experts is fostering a richer, more comprehensive understanding of patient needs and treatment responses. In parallel, emerging data analytics and digital health applications are playing a supplementary role by providing actionable insights that inform both design improvements and clinical decision-making. Such shifts have established a new benchmark for performance and efficiency, carving out a path for sustained innovation and market expansion.

Key Insights into Market Segmentation

Market segmentation within the extracorporeal CO2 removal landscape offers a nuanced understanding of the diverse dynamics at play. The segmentation based on product types is particularly revealing, as it highlights the evolution of devices from traditional ECCO2R machines to advanced membrane oxygenators and sophisticated roller pump systems. In parallel, the segmentation based on access delineates two principal approaches: arteriovenous and venovenous. Each modality represents substantially different methodologies in patient management and hemodynamic control.

Further differentiation is seen when examining the mode of operation, where a distinct contrast exists between automated systems and manual systems. This delineation underscores the growing preference for automation, which has been instrumental in reducing operational complexities and enhancing overall performance. Additionally, when the focus shifts to applications, the market clearly characterizes distinct usage patterns, such as addressing Acute Respiratory Distress Syndrome, providing a bridge to lung transplant, and managing Chronic Obstructive Pulmonary Disease. These applications further dictate the therapeutic strategies and impact the design of devices.

Lastly, segmentation by end user surfaces variations in demand across different care settings, ranging from ambulatory surgical centers and home care settings to hospitals and specialty clinics. Each of these segments provides unique insights concerning regional disparities, clinical requirements, and potential for technological adoption. The intersection of these segmentation parameters paints a comprehensive picture that guides manufacturers and policy makers in tailoring their strategies to meet both current and future market needs.

Based on Product Types, market is studied across ECCO2R Machines, Membrane Oxygenators, and Roller pump.

Based on Access, market is studied across Arteriovenous and Venovenous.

Based on Mode of Operation, market is studied across Automated Systems and Manual Systems.

Based on Application, market is studied across Acute Respiratory Distress Syndrome, Bridge to Lung Transplant, and Chronic Obstructive Pulmonary Disease.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Specialty Clinics.

Significant Regional Insights Shaping the Market

The global landscape for extracorporeal CO2 removal devices reveals considerable regional variations, each contributing distinctively to the overall growth trajectory. In the Americas, the market is characterized by robust healthcare infrastructure and widespread adoption of advanced medical technologies. This region's dynamic regulatory environment and strong emphasis on patient outcomes foster a conducive setting for both established companies and emerging players to invest in innovative solutions.

Across Europe, the Middle East, and Africa, market dynamics are influenced by a confluence of high clinical demand coupled with strategic governmental initiatives. Advanced healthcare systems, in tandem with active research and collaboration networks, are generating significant interest in devices that offer improved safety profiles and operational simplicity. This region's challenges often spur innovative solutions tailored to meet the dual demands of efficacy and cost efficiency.

In Asia-Pacific, rapid economic development and expanding healthcare access are driving market growth. The region combines a high volume of patient populations with an increasing number of private and public healthcare institutions. With a keen interest in incorporating breakthrough healthcare technologies, this market is witnessing accelerated innovations, particularly in terms of integrating automation and digital solutions into device operations. Together, these regional insights underscore a landscape defined by varied clinical practices, economic drivers, and regulatory frameworks, each contributing uniquely to the overall evolution of the market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

A highly competitive environment characterizes the emerging market of extracorporeal CO2 removal devices, where several leading companies are driving forward critical innovations. Industry leaders such as Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., and Dragerwerk AG & Co. KGaA are at the forefront of advancing product capabilities and refining design protocols. At the same time, Edwards Lifesciences Corporation, Estor S.p.A, and Fresenius Medical Care AG have established themselves as key players by focusing on rigorous clinical validations and robust quality standards.

Not far behind are Getinge AB, Inspira-Technologies OXY B.H.N. LTD, and Koninklijke Philips N.V., each contributing uniquely to the technological ecosystem through collaborative research and targeted development projects. Prominent entities such as LivaNova PLC, Medica S.p.A, and MicroPort Scientific Corporation further underscore the sector's dynamism by consistently pushing the envelope on performance enhancements and usability. These companies are complemented by the pioneering efforts of Nikkiso Co., Ltd., NovaLung GmbH, and Terumo Corporation, which have all implemented strategies ranging from strategic partnerships to comprehensive global market deployment.

Other notable contributors include X-COR Therapeutics and XENIOS AG by Fresenius Medical Care AG & Co. KGaA, whose continued commitment to innovation and excellence has helped fortify market positions and drive industry-wide standards. By leveraging advanced research, adaptive manufacturing processes, and expansive clinical networks, these companies have not only set new benchmarks in device efficacy but have also effectively shaped industry trends. Their collective efforts are ensuring that extracorporeal CO2 removal technology remains at the cutting edge of respiratory care solutions.

The report delves into recent significant developments in the Extracorporeal CO2 Removal Devices Market, highlighting leading vendors and their innovative profiles. These include Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Estor S.p.A, Fresenius Medical Care AG, Getinge AB, Inspira-Technologies OXY B.H.N. LTD, Koninklijke Philips N.V., LivaNova PLC, Medica S.p.A, MicroPort Scientific Corporation, Nikkiso Co., Ltd., NovaLung GmbH, Terumo Corporation, X-COR Therapeutics, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA. Actionable Recommendations for Industry Leaders

Industry leaders should consider a strategic roadmap that embraces both innovation and operational efficiency to remain competitive in the evolving market of extracorporeal CO2 removal devices. It is recommended that companies invest in robust research and development programs to harness the benefits of automation and digital integration, which have been shown to enhance device reliability and patient safety. By focusing on continuous improvement in performance, companies can address the growing clinical needs effectively and maintain regulatory compliance.

Moreover, a diversified market approach that leverages insights from key segmentations-ranging from product type and access method to mode of operation, application, and end-user preferences-is essential. Organizations need to capitalize on the data-driven trends that point to the rising demand for automated systems and minimally invasive technologies. Building strategic alliances with clinical experts and academic institutions can further aid in refining design specifications and fast-tracking product innovation.

Navigating regional differences by tailoring solutions to meet specific market demands is crucial. Companies should adopt targeted marketing strategies in regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific, while remaining agile in response to evolving local regulatory frameworks. Embracing a customer-centric approach, with a focus on post-market surveillance and real-time feedback, will enable continuous enhancements and foster greater consumer trust. In summary, a balanced investment in technology, collaboration, and regional market intelligence will help solidify long-term competitive advantages.

Conclusion: A Future Poised for Innovation and Growth

In conclusion, the landscape of extracorporeal CO2 removal devices is undergoing significant transformation, driven by technological advancements, diversified market segmentations, and dynamic regional trends. The evolution from traditional solutions to more automated, efficient, and patient-friendly systems underscores the significant progress made in the field. With heightened regulatory scrutiny and the ongoing commitment of leading companies towards innovation, the industry is positioned for robust growth.

This comprehensive analysis reveals that harnessing the potential of emerging technologies while recognizing the unique clinical demands across regions is key to sustaining success. Industry stakeholders are well-advised to leverage actionable insights derived from market segmentation and regional analyses. With strategic investments and collaborative efforts, the market can achieve unprecedented levels of performance and efficiency, ultimately redefining standards in respiratory care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of acute respiratory failure, severe asthma, and COPD
      • 5.1.1.2. Growing awareness among healthcare professionals about non-invasive CO2 removal solutions
      • 5.1.1.3. Increasing healthcare infrastructure and rise in per capita expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Technical integration risk associated with operating ECCO2R systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D and funding for technological advancements in extracorporeal CO2 removal devices
      • 5.1.3.2. Increasing regulatory product approval and clinical trials for the device
    • 5.1.4. Challenges
      • 5.1.4.1. Managing supply chain complexities and ensuring device availability in remote healthcare settings
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Types: Growing usage of ECCO2R machines in extracorporeal CO2 removal to treat severe pulmonary complications
    • 5.2.2. Application: Expanding application of Acute respiratory distress syndrome devices in extracorporeal CO2 removal devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Extracorporeal CO2 Removal Devices Market, by Product Types

  • 6.1. Introduction
  • 6.2. ECCO2R Machines
  • 6.3. Membrane Oxygenators
  • 6.4. Roller pump

7. Extracorporeal CO2 Removal Devices Market, by Access

  • 7.1. Introduction
  • 7.2. Arteriovenous
  • 7.3. Venovenous

8. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

  • 8.1. Introduction
  • 8.2. Automated Systems
  • 8.3. Manual Systems

9. Extracorporeal CO2 Removal Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Acute Respiratory Distress Syndrome
  • 9.3. Bridge to Lung Transplant
  • 9.4. Chronic Obstructive Pulmonary Disease

10. Extracorporeal CO2 Removal Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Americas Extracorporeal CO2 Removal Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Extracorporeal CO2 Removal Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal CO2 Removal Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Inspira Technologies enhances its INSPIRA ART100 system with advanced alarm troubleshooting and automated critical care guidance
    • 14.3.2. NSW launches mobile ECMO referral service that deploys specialist pediatric teams for immediate lifesaving care
    • 14.3.3. The ROMEO trial secured GBP 2.1 million in NIHR funding
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aferetica Srl
  • 2. ALung Technologies, Inc. by LivaNova PLC
  • 3. Baxter International Inc.
  • 4. Dragerwerk AG & Co. KGaA
  • 5. Edwards Lifesciences Corporation
  • 6. Estor S.p.A
  • 7. Fresenius Medical Care AG
  • 8. Getinge AB
  • 9. Inspira-Technologies OXY B.H.N. LTD
  • 10. Koninklijke Philips N.V.
  • 11. LivaNova PLC
  • 12. Medica S.p.A
  • 13. MicroPort Scientific Corporation
  • 14. Nikkiso Co., Ltd.
  • 15. NovaLung GmbH
  • 16. Terumo Corporation
  • 17. X-COR Therapeutics
  • 18. XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

  • FIGURE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 236. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024